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Caspase-8 or cellular FLICE-like inhibitor protein
(cFLIP) deficiency leads to embryonic lethality in
mice due to defects in endothelial tissues. Cas-
pase-8/ and receptor-interacting protein kinase-3
(RIPK3)/, but not cFLIP/ and RIPK3/, double-
knockout animals develop normally, indicating that
caspase-8 antagonizes the lethal effects of RIPK3
during development. Here, we show that the acute
deletion of caspase-8 in the gut of adult mice induces
enterocyte death, disruption of tissue homeostasis,
and inflammation, resulting in sepsis and mortality.
Likewise, acute deletion of caspase-8 in a focal
region of the skin induces local keratinocyte death,
tissue disruption, and inflammation. Strikingly,
RIPK3 ablation rescues both phenotypes. However,
acute loss of cFLIP in the skin produces a similar
phenotype that is not rescued by RIPK3 ablation.
TNF neutralization protects from either acute loss
of caspase-8 or cFLIP. These results demonstrate
that caspase-8-mediated suppression of RIPK3-
induced death is required not only during develop-
ment but also for adult homeostasis. Furthermore,
RIPK3-dependent inflammation is dispensable for
the skin phenotype.INTRODUCTION
Upon death receptor ligation, caspase-8 is recruited to initiator
complexes through the adaptor molecule Fas (TNFRSF6)-asso-
ciated protein with Death Domain (FADD) and forms active ho-
modimers by induced proximity, propagating the apoptotic
signal (Fuentes-Prior and Salvesen, 2004). Cellular FLICE-like in-
hibitor protein (cFLIPL) (FLIP), a caspase-8 homolog lacking the
catalytic cysteine, is recruited to the same complexes, forms
heterodimers with caspase-8, and blocks the formation of the340 Cell Reports 5, 340–348, October 31, 2013 ª2013 The Authorsproapoptotic caspase-8 homodimers (Krueger et al., 2001). Cas-
pase-8-, FADD-, or FLIP-deficient embryos die around embry-
onic day 10.5 associated with a failure to remodel the yolk sac
vasculature (Varfolomeev et al., 1998; Yeh et al., 1998, 2000),
an effect unrelated to the ability of caspase-8 to promote
apoptosis. Further, animals with conditional deletion of cas-
pase-8 with endothelium-specific Tie-1 promoter die with the
same gross pathology and at the same developmental stage
as do caspase-8-deficient embryos (Kang et al., 2004). No
embryonic lethality was observed when caspase-8 was deleted
elsewhere, including the heart (Dillon et al., 2012), liver (Kang
et al., 2004), myeloid cells (Kang et al., 2004), and B or T lympho-
cytes (Beisner et al., 2005; Salmena et al., 2003). In skin (Kova-
lenko et al., 2009; Lee et al., 2009), or gut (Gu¨nther et al.,
2011), deletion of caspase-8 results in postnatal lethality due
to loss of barrier function and inflammation.
Receptor-interacting protein kinase-3 (RIPK3) promotes an
alternative mode of cell death with characteristics of necrosis,
often called ‘‘necroptosis’’ (Zhang et al., 2009). Ablation of
RIPK3 fully rescues the development of mice lacking caspase-
8, FADD, or both FADD and FLIP (Dillon et al., 2012; Kaiser
et al., 2011; Oberst et al., 2011). These and other approaches
showed that the FADD-induced heterodimer of caspase-8 and
FLIP suppresses RIPK3-mediated lethality (Dillon et al., 2012;
Oberst et al., 2011). In this paper, we address whether the devel-
opmental roles of caspase-8 and FLIP in suppressing the lethal
effects of RIPK3 persist into adult life.
RESULTS AND DISCUSSION
In order to achieve acute, systemic deletion of caspase-8 in adult
animals, Rosa26.CreER+ (CreER+), caspase-8flox/flox (casp8f/f)
animals were gavaged with tamoxifen. Acute caspase-8 deletion
through tamoxifen gavage induced severe weight loss and
lethality in Cre+ animals, but not in Cre littermates (Figures 1A
and 1B). Cre+ animals that survived the treatment recovered
weight over time (Figure S1A). Neither the activation of Cre in
wild-type (WT) animals (Figure S1B) nor the deletion of an unre-
lated gene (Figure S1C) induced weight loss. Therefore, the ef-
fects were specifically caused by acute caspase-8 ablation.
Figure 1. Acute Deletion of Caspase-8 Induces Cell Death, Tissue Damage, Loss of Weight, and Lethality
Rosa26.CreER, casp8f/f (CreER) and Rosa26.CreER+, casp8f/f (CreER+) animals were gavaged with 1 mg tamoxifen per 25 g animal body weight for 6
consecutive days.
(A and B) Animals were observed over 20 days for weight loss (A) and lethality (B). Error bars correspond to SD.
(legend continued on next page)
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To assess the efficiency of gene recombination, CreER+ ani-
mals were crossed to lox/stop/lox-yellow fluorescent protein
(YFP) (LSL-YFP) animals. Upon gavage, these animals showed
widespread YFP expression throughout the gut (Figure S1D),
lymph nodes, spleen, thymus (Figure S1E), and peripheral blood
leukocytes (Figure S1F). Direct assessment of caspase-8 dele-
tion was further performed by PCR in tamoxifen-treated CreER+,
casp8f/f animals. Gene deletion was detected in all tissues and
was nearly complete throughout the gut (Figure S1G), consistent
with the YFP expression pattern in the LSL-YFP reporter animal
(Figures S1D–S1F).
Histology during the period of acute weight loss showedmajor
disruption of tissue homeostasis and organization, with vacuola-
tion of the villi, enterocyte death, marked inflammation, and infil-
tration of immune cells (Figures 1C–1E and S1H). The disruption
of tissue homeostasis occurred throughout the intestines,
including the small intestine (Figure S1H, top row), cecum (Fig-
ure 1C), and colon (Figure S1H, bottom row). Infiltration was by
macrophages (F4/80+) and neutrophils (Ly6B.2+), with a minor
infiltration of T cells (CD3+; Figure 1E). Analysis of the peripheral
blood leukocytes showed a marked increase in granulocytes
(Figure 1F).
No significant alterations were observed in other organs,
including liver, brain, heart, kidney, lungs, and lymphoid organs
during the course of these experiments (data not shown).
Blood cultures from casp8-deleted animals detected gut-
resident microorganisms (Figure S2A), and oral-gavaged fluo-
rescein isothiocyanate (FITC)-dextran was detected in the
peripheral blood of CreER+, casp8f/f animals, indicating
abnormal gut permeability (Figure S2B). Therefore, the weight
loss and lethality in CreER+, casp8f/f animals were most likely
related to disruption of the gut epithelial barrier.
Histology of the gut in the pre-weight-loss phase upon casp8
deletion revealed early enterocyte cell death by hematoxylin and
eosin staining (H&E) and terminal deoxynucleotidyl transferase
deoxyuridine triphosphate nick end labeling (TUNEL) staining,
especially in the crypts and in the base of the villi, before any
signs of inflammation (Figures 1GandS1I). Most TUNEL-positive
cells did not stain for cleaved caspase-3 (Figure 1H), indicating
that apoptosis was not the prevalent mode of cell death. In addi-
tion to apoptosis, TUNEL positivity in vivo can result from
DNase-II-mediated digestion of engulfed nonapoptotic cell
corpses (McIlroy et al., 2000). Indeed, ultrastructure of these
dying cells resembled that of necrotic cells (Figure 1D). Although
there is no specific marker for necroptosis, the combination of
H&E, TUNEL, cleaved caspase-3 staining, and ultrastructure is
evidence for nonapoptotic, necrosis-like cell death (Bonnet
et al., 2011; Gu¨nther et al., 2011; Welz et al., 2011).
The liver, a major site for the conversion of tamoxifen into its
active form 4-hydroxytamoxifen (4OHT), was not affected by(C) Day +9 cecum sections from tamoxifen-treated animals were stained with he
(D) Transmission electron microscopy of proximal small intestine crypts at day +
(E) Proximal small intestine sections at day +9 were immunostained for T cells (a
(F) Peripheral blood leukocytes at day +9 were stained with anti-CD11b and anti-
show cell size (forward scatter – pulse area [FSC-A]) versus granulosity (side sc
anti-CD11b.
(G and H) Proximal small intestine sections from day +6 were stained for TUNEL
See also Figures S1 and S2.
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sitive to concavalin A (ConA)-induced cell death that can be
blocked by the RIPK1 inhibitor, necrostatin-1 (Jouan-Lanhouet
et al., 2012). However, ConA-injected, RIPK3-deficient animals
displayed the same levels of liver damage as their control litter-
mates (Figures S3A–S3C). Damaged areas in the liver were
cleaved caspase-3+, indicating apoptosis (Figures S3C and
S3D). This is in agreement with the finding that liver-specific
ablation of caspase-8 has no pathological effect (Kang et al.,
2004). Moreover, neither tumor necrosis factor (TNF) nor anti-
CD95, in combination with the pan-caspase inhibitor zVAD-
fmk, induces liver necrosis (Chandler et al., 1998; Ku¨nstle
et al., 1997), and liver-specific ablation of caspase-8 is protective
against anti-CD95-induced liver damage (Kang et al., 2004).
Hence, there is no evidence to date that liver cells can undergo
RIPK3-dependent necrosis; rather, they seem to be refractory
to this type of cell death.
Embryonic lethality in caspase-8/mice can be fully rescued
by ablation of RIPK3 (Kaiser et al., 2011; Oberst et al., 2011);
therefore four genotypes were examined: CreER, casp8f/f,
ripk3+/+; CreER, casp8f/f, ripk3/; CreER+, casp8f/f, ripk3+/+;
and CreER+, casp8f/f, ripk3/. Strikingly, RIPK3 deficiency
protected animals from the weight loss induced by acute
casp8 deletion (Figures 2A and S2C). Moreover, no lethality
was observed in the CreER+, casp8f/f, ripk3/ animals
(Figure 2B).
A marked reduction in the number of dying enterocytes was
observed during the pre-weight-loss phase in CreER+, casp8f/f,
ripk3/ animals as compared to their CreER+, casp8f/f, ripk3WT
littermates (Figure 2C), as was confirmed by TUNEL and cleaved
caspase-3 staining (Figures 2D, S2D, and S2E) and ultrastruc-
ture (Figure 2E). RIPK3-dependent death of enterocytes during
the early phases of tamoxifen treatment was associated with
more intact gut tissue architecture at later time points (Fig-
ure S2F). At the peak of weight loss and disruption of gut homeo-
stasis in CreER+, casp8f/f, ripk3WT animals, CreER+, casp8f/f,
ripk3/ mice showed dramatically lower levels of edema and
infiltration of the gut (Figure S2F), including the small intestine
(Figure 2F) and the cecum (Figure S2G). No FITC-dextran or
bacteria were found in the peripheral blood in the these animals,
indicating that there was no gut epithelial barrier breakdown or
subsequent infection (Figures S2A and S2B).
Collectively, these findings demonstrate that caspase-8 is
required for normal gut homeostasis during adulthood, and
upon its acute deletion, RIPK3-mediated effects, including ne-
crosis, can induce rapid and extensive gut damage, leading to
epithelial barrier disruption and sepsis.
Skin homeostasis can also be severely affected by tissue-
specific loss of caspase-8 during development (Kovalenko
et al., 2009; Lee et al., 2009). Therefore, we painted skin withmatoxylin and eosin.
6. Arrow points to necrotic cell.
nti-CD3), macrophages (anti-F4/80), and neutrophils (anti-LY-6B.2).
GR-1 and then analyzed by fluorescence-activated cell sorting. Upper panels
atter – pulse area [SSC-A]), whereas the lower panels show anti-GR-1 versus
(G) or cleaved caspase-3 (H). Triple asterisks denote p < 0.001.
A C
B
D
E
F
Figure 2. RIPK3 Deficiency Protects from Acute Deletion of Caspase-8
Rosa26.CreER, casp8f/f, ripk3+/+ (CreER, RIPK3WT); Rosa26.CreER, casp8f/f, ripk3/ (CreER, RIPK3/); Rosa26.CreER+, caspase-8flox/flox, RIPK3+/+
(CreER+, RIPK3WT); and Rosa26.CreER+, casp8f/f, ripk3/ (CreER+, RIPK3/) animals were gavaged with 1 mg tamoxifen per 25 g animal body weight for 6
consecutive days.
(A and B) Animals were observed over 25 days for weight loss (A) and lethality (B). Error bars correspond to SD.
(C) Day +6 proximal small intestine sections from tamoxifen-treated CreER+, RIPK3WT and CreER+, RIPK3/ animals were stained with hematoxylin and eosin.
Red circles highlight dead cells.
(D) Proximal small intestine sections were stained for TUNEL and cleaved caspase-3, and the number of TUNEL-positive or cleaved caspase-3 positive cells per
100 crypts was determined by manual counts. Error bars correspond to SD.
(E) Transmission electron microscopy of proximal small intestine crypts at day +6. Arrow points to necrotic cell.
(F) Day +9 proximal small intestine sections from tamoxifen-treated CreER+, RIPK3WT and CreER+, RIPK3/ animals were immunostained for neutrophils (anti-
LY-6B.2; left panel) or macrophages (anti-F4/80; right panel). Triple asterisks denote p < 0.001.
See also Figures S2 and S3.4OHT to assess the effects of a localized, acute loss of cas-
pase-8 in adult animals. YFP expression in CreER+, LSL-YFP
animals was analyzed 24 hr after the last day of paintingCshowed YFP expression, whereas no YFP+ cells were
detected in the vehicle-only painted area of the same animal
(Figure 3A).ell Reports 5, 340–348, October 31, 2013 ª2013 The Authors 343
(legend on next page)
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Local deletion of casp8 in the skin induced a large ulcerative
area, with epidermal hyperplasia and marked superficial hyper-
keratosis, forming a thick crust (Figure 3B, left panel), with dys-
keratotic foci and central pustule formation, edema, and immune
cell infiltration (Figure 3B, right panel). Enhanced keratinocyte
death was evidenced by TUNEL staining (Figure 3C). In contrast,
4OHT-painted areas from CreER+, casp8f/f, ripk3/ mice
showedminimal epidermal hyperplasia, rare dead keratinocytes,
and minimal dermal inflammation (Figures 3B and 3C). Similarly,
embryonic skin-specific deletion of FADD induced chronic skin
inflammation, which was also blocked by concurrent ablation
of RIPK3 (Bonnet et al., 2011).
All previous models of skin-specific Cre-induced deletion of
caspase-8 or FADD used either the K5 or the K14 promoters,
which are first expressed during embryonic development (Bon-
net et al., 2011; Kovalenko et al., 2009; Lee et al., 2009). It is,
therefore, possible that the effects seen in young animals
were the result of loss during development. This same argument
can be made for models of gut-specific deletion of caspase-8,
FADD, or FLIP employing the Villin-Cre promoter, which is
also expressed during embryogenesis (Gu¨nther et al., 2011;
Piao et al., 2012; Welz et al., 2011). Our results demonstrate
that caspase-8 is required not only during development but
also is essential to maintain skin and gut homeostasis in adult
animals.
Recently, RIPK3 activation was suggested to be involved not
only in necroptosis induction, but also in inflammatory responses
(Kang et al., 2013; Vince et al., 2012). Ripk3/ bone marrow-
derived macrophages (BMDM), however, presented similar
levels of proinflammatory cytokine production compared to
RIPK3-sufficient BMDM both after stimulation with lipopolysac-
charide (LPS) or infection with E. coli (Figure S4A). Likewise,
RIPK3 deficiency did not influence LPS-induced cytokine pro-
duction in vivo (Figure S4B). The detection of RIPK3-dependent
necrosis at early time points, when no signs of inflammation were
observed (Figure S1I), together with the similar proinflammatory
response to LPS between the RIPK3-sufficient and -deficient
mice (Figures S4A and S4B) suggests that cell death may be
the major driving force behind the damaging outcomes of cas-
pase-8 loss in adult animals.
To directly test this, a model in which cflar (encoding FLIP),
rather than casp8, is acutely deleted in the skin was developed.
In the absence of FLIP, caspase-8 fails to block RIPK3-medi-
ated necroptosis (Oberst et al., 2011) and can also sensitize
to FADD-caspase-8-dependent apoptosis (Dillon et al., 2012;
Irmler et al., 1997; Yeh et al., 2000). 4OHT-painted skin areas
from CreER+, cflarf/f, ripk3+/+ presented a similar phenotype to
that observed in acute casp8 deletion, with epidermal hyperpla-
sia, superficial hyperkeratosis, and the formation of a thick crustFigure 3. Acute Deletion of Caspase-8 or FLIP in the Skin by 4-Hydroxyt
Animals were shaved in two distinct dorsal areas. The shaved area around the nec
the tail base was painted only with vehicle.
(A) Histological sections from the painted skin areas from Rosa26.CreER, LSL-Y
taken the day after the last painting and stained with anti-GFP to detect YFP exp
(B and C) Rosa26.CreER, casp8f/f, ripk3+/+ (CreER, RIPK3WT); Rosa26.CreER+
(CreER+, RIPK3/) were painted four times, and at day +12, (B) photos and H&
(D–F) Rosa26.CreER, cflarf/f, ripk3+/+ (CreER, RIPK3WT); Rosa26.CreER+, cflar
RIPK3/) were painted two times, and at day +10, (D) photos and H&E-stained s
C(Figure 3D, left panel), with enhanced edema and infiltration
(Figure 3D, right panels) as well as higher levels of cell death,
evidenced either by TUNEL (Figure 3E) or cleaved caspase-3
staining (Figure 3F). In contrast to acute casp8 deletion,
apoptosis rather than necrosis was responsible for the cell
death. Further, RIPK3 ablation was not able to prevent or lessen
the skin disease, as CreER+, cflarf/f, ripk3/ presented similar
levels of skin damage when painted with 4OHT (Figures 3D–
3F and S4C).
Therefore, regardless of the mode of cell death, the conse-
quences of acute deletion of either caspase-8 or FLIP appear
to produce similar pathologies, yet with different time courses
(Figures S4C and S4D), perhaps due to the relative stabilities
of the proteins (Fulda et al., 2000). Because, in the latter case,
cells can only undergo apoptosis and the phenotype developed
independently of RIPK3-mediated pathways, it is reasonable to
conclude that RIPK3-induced inflammation is not required in
this model. Further, this implies that apoptosis and RIPK3-medi-
ated necrosis must be actively suppressed to maintain skin
tissue homeostasis, which is in agreement with the observation
that FLIP embryonic lethality is only rescued by ablation of
both RIPK3 and FADD (Dillon et al., 2012).
We suggest that either necroptotic or apoptotic cell death is
responsible for the inflammatory effects. However, whereas
necrosis is known to be proinflammatory, apoptosis is not
(Green, 2010). Thus, it is possible that the inflammatory response
is due to cell-death-mediated loss of barrier function, rather than
an effect of dying cells on the inflammatory response. Indeed,
increased production of interleukin (IL)-1b in the skin correlates
with the skin damage rather than with RIPK3-induced inflamma-
tion (Figures 4A and 4B). Moreover, loss of gut tissue homeosta-
sis by embryonic gut-specific ablation of FADD is attenuated by
treatment with antibiotics as well as by germ-free conditions
(Gu¨nther et al., 2011).
Caspase-8 was suggested to suppress the exacerbated
RIPK3-mediated inflammatory response to normal skin cornifi-
cation via RIG-I and its adaptor protein mitochondrial antiviral-
signaling protein (MAVS) (Rajput et al., 2011; Wallach et al.,
2010). To assess the contribution of this pathway to the
observed skin phenotype, CreER+, casp8f/f, mavs/ animals
were generated. We found, however, that the pathological
effects of acute deletion of casp8 in the skin were not rescued
by ablation of MAVS (Figure S4E), demonstrating that cas-
pase-8 suppression of the RIG-I/MAVS pathway is not respon-
sible for the loss of skin homeostasis.
TNF, via its receptor TNF-R1, is the best-described trigger of
necroptosis, both in vitro and in vivo, and it is also a well-known
inducer of apoptosis (Weinlich et al., 2011). Upon acute deletion
of either casp8 or cflar, TNF is produced at detectable levels inamoxifen Painting Produces Local Inflammation and Tissue Damage
k was painted with 4-hydroxytamoxifen (4OHT), whereas the shaved area near
FP (CreER, LSL-YFP) and Rosa26.CreER+, LSL-YFP (CreER+, LSL-YFP) were
ression.
, casp8f/f, ripk3+/+ (CreER+, RIPK3WT); and Rosa26.CreER+, casp8f/f, ripk3/
E-stained sections or (C) TUNEL-stained sections were produced.
f/f, ripk3+/+ (CreER+, RIPK3WT); and Rosa26.CreER+, cflarf/f, ripk3/ (CreER+,
ections, (E) TUNEL-stained sections, or (F) cleaved caspase-3 were produced.
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Figure 4. Neutralization of TNF Protects from the Deleterious Effects of Caspase-8 or FLIP Acute Deletion
Animals were shaved in two distinct dorsal areas. The shaved area around the neck was painted with 4-hydroxytamoxifen (4OHT), whereas the shaved area near
the tail base was painted only with vehicle.
(A and B) IL-1b levels in the skins of (A) Casp8f/f animals at day +10 or (B) cflarf/f animals at day +5. Error bars correspond to SD.
(C) TNF levels in the skins of casp8f/f (Casp8 flox) animals at day +10 or cflarf/f (FLIP flox) animals at day +5. Error bars correspond to SD.
(D–F) CreER+, cflarf/f animals were intraperitoneally (i.p.) injected at days1, +1, and +3with 0.5mg of TNF antibodies (clone XT3.11) or isotype control antibodies
(clone HRPN), and examples of (D) photos, (E) sections stained with hematoxylin and eosin, and (F) cleaved caspase-3-staining sections were produced at
day +8.
(G) CreER+, casp8f/f animals were gavaged with 1 mg tamoxifen per 25 g animal body weight for 6 consecutive days and i.p. injected at days +0, +2, and +4 with
0.5 mg of two different neutralizing TNF antibodies (#1, XT3.11; #2, HB10649) or isotype control (clone HRPN). Weight loss was followed for 18 days. Error bars
correspond to SD.
(H) CreER+, cflarf/f animals were treated as in (G) but gavaged only twice, at days +0 and +2, and their weights were tracked for 10 days. The asterisk denotes p <
0.05. The triple asterisks denote p < 0.001. n.s., not statistically significant. Error bars correspond to SD.
See also Figure S4.
346 Cell Reports 5, 340–348, October 31, 2013 ª2013 The Authors
the skin at early stages of disease (Figure 4C). Therefore,
CreER+, cflarf/f, animals were injected with neutralizing anti-
TNF or control isotype antibodies and painted with 4OHT (Fig-
ures 4D and 4E). Whereas all isotype-injected animals fully
developed the skin disease, anti-TNF treatment resulted in a
marked protection: either they did not show any signs of the dis-
ease or presented much milder lesions (Figures 4D–4F).
To further analyze the role of TNF, CreER+, casp8f/f or
CreER+, cflarf/f animals were gavaged with tamoxifen simulta-
neously with injections of two different neutralizing TNF anti-
bodies or isotype control. Both TNF antibodies protected from
the effects of acute deletion of casp8 (Figure 4G) or cflar (Fig-
ure 4H). These data indicate that, independent of the cell death
type induced, TNF plays a central role in the onset of the
disease.
The therapeutic use of pan-caspase inhibitors has been
proposed and, to date, no severe toxic effects of these inhibitors
have been reported in mice (Callus and Vaux, 2007) or humans
(Pockros et al., 2007; Ratziu et al., 2012). Genetic studies that
rescued caspase-8 deficiency in vivo (Kaiser et al., 2011; Oberst
et al., 2011), as well as in vitro studies on inhibition of RIPK3-
dependent necrosis (Oberst et al., 2011), have shown that the
protease activity of caspase-8 is required for its protective
effects. Therefore, in light of our results, a closer evaluation of
how these inhibitors affect caspase-8 activity in vivo, as well
as their pharmacokinetics, bioavailability, and tissue distribution,
is warranted. This might be particularly important in patients with
elevated levels of circulating TNF, as the addition of exogenous
TNF to animals lacking intestinal caspase-8 strikingly exacer-
bated damage to gut tissue (Gu¨nther et al., 2011). Furthermore,
TNF-induced shock aswell as hyperacute shock induced by TNF
in combination with caspase inhibitors severely impact the gut
and are mainly mediated by RIPK3 (Duprez et al., 2011; Linker-
mann et al., 2012). Attempts to generate pan-caspase inhibitors
that may be more active in vivo may therefore reveal toxicities
associated with the effects we describe.
EXPERIMENTAL PROCEDURES
Tamoxifen Treatments
To induce systemic deletion of caspase-8, animals were gavaged for 6
consecutive days with tamoxifen (T5648, Sigma-Aldrich) dissolved in sun-
flower seed oil (S5007, Sigma-Aldrich) at a concentration of 1 mg tamoxifen
per 25 g of animal body weight per day. Weight loss, morbidity, and mortality
were assessed every day. Acute deletion of FLIPwas induced by two rounds of
gavage with a 48 hr interval between them.
To induce localized deletion of caspase-8 or cFLIP in the skin, animals were
shaved in two different dorsal areas (one around the neck and one near the tail
base) using a hair trimmer. The dorsal area around the neck was painted four
times, once every other day, for casp8f/f animals and twice, once every other
day, for cflarf/f animals with 100 ml of 10 mg/ml 4-hydroxytamoxifen (H6278,
Sigma-Aldrich) dissolved in ethanol. The dorsal area near the tail base was
painted only with vehicle and served as an internal control area.
For further experimental procedures, please see the Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
four figures and can be found with this article online at http://dx.doi.org/10.
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